Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis.
Rajesh M
RM
Prabhu
Robert
R
Orenstein
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001922:Brain Abscess / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D002176:Candida albicans; D002177:Candidiasis / Q000188:drug therapy*; D000077336:Caspofungin; D054714:Echinocandins; D004696:Endocarditis / Q000150:complications* / Q000188:drug therapy; D015725:Fluconazole / Q000627:therapeutic use; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D055666:Lipopeptides; D008297:Male; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D017211:Treatment Failure
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; C068538:liposomal amphotericin B; D000666:Amphotericin B; D015725:Fluconazole; D000077336:Caspofungin